opc 14597

Aripiprazole (OPC-14597) is an antipsychotic agent that is structurally related to piperazines and quinolones. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A.

Aripiprazole-D8 is the deuterium-labeled Aripiprazole. Aripiprazole (T1566) is a human 5-HT1A receptor partial agonist (Ki: 4.2 nM).

Aripiprazole (OPC-14597) monohydrate is an atypical antipsychotic that is a potent, high-affinity partial agonist of the dopamine D2 receptor.Aripiprazole monohydrate is an inverse agonist of the 5-HT2B and 5-HT2A receptors, and is active on 5-HT1A, 5-HT2C, D3 and D4. Aripiprazole monohydrate can be used to study schizophrenia and COVID19.

Aripiprazole (Standard) is a reference standard for research and analysis in studies involving Aripiprazole. Aripiprazole (OPC-14597) is an antipsychotic agent that is structurally related to piperazines and quinolones. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A.